Compugen News

Compugen to Present at Upcoming Antibody Industrial Symposium

HOLON, Israel, June 17, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced

PR NewswireJun 17 07:00 ET

Compugen (CGEN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Yahoo FinanceJun 4 09:55 ET

Express News | Compugen To Receive $5M Milestone Payment From AstraZeneca Following Dosing Of First Patient In Second Phase 3 Trial Of Rilvegostomig

BenzingaMay 30 07:05 ET

Compugen Is Maintained at Buy by Truist Securities

Compugen Is Maintained at Buy by Truist Securities

Dow JonesMay 21 08:19 ET

Express News | Truist Securities Maintains Buy on Compugen, Lowers Price Target to $4

BenzingaMay 21 08:08 ET

Compugen Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/21/2024 118.58% Truist Securities $5 → $4 Maintains Buy 03/08/2024 173.22% Truist Securities $4 → $5 Ma

BenzingaMay 21 08:07 ET

Express News | Compugen Ltd : Truist Securities Cuts Target Price to $4 From $5

ReutersMay 21 00:12 ET

Earnings Call Summary | Compugen(CGEN.US) Q1 2024 Earnings Conference

The following is a summary of the Compugen Ltd. (CGEN) Q1 2024 Earnings Call Transcript:Financial Performance:Compugen reported a cash balance of approximately $101.3 million as of Q1 2024, including

moomoo AIMay 20 18:04 ET · Conference Call

Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating

Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating.

MT NewswiresMay 20 14:08 ET

PTC Therapeutics, Oragenics, GT Biopharma Among Healthcare Movers

Seeking AlphaMay 20 10:00 ET

Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates

Compugen (CGEN) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.10.

Yahoo FinanceMay 20 08:10 ET

Compugen Announces Promising Q1 2024 Updates

TipRanksMay 20 07:58 ET

Express News | Compugen Expects Its Cash And Cash-related Balances Of $101.3M Together With A $30M Milestone Payment On COM503 IND Clearance Expected In 2024, Is Expected To Provide Cash Runway Into 2027

BenzingaMay 20 07:05 ET

Compugen | 6-K: Report of foreign private issuer (related to financial reporting)

SEC announcementMay 20 07:05 ET · Announcements

Compugen Q1 2024 GAAP EPS $(0.08) Beats $(0.11) Estimate, Sales $2.559M Miss $6.213M Estimate

Compugen Q1 2024 GAAP EPS $(0.08) Beats $(0.11) Estimate, Sales $2.559M Miss $6.213M Estimate

BenzingaMay 20 07:03 ET

Earnings Flash (CGEN) COMPUGEN Reports Q1 Revenue $2.6M, Vs. Street Est of $1.2M

07:03 AM EDT, 05/20/2024 (MT Newswires) -- Earnings Flash (CGEN) COMPUGEN Reports Q1 Revenue $2.6M, vs. Street Est of $1.2M

MT NewswiresMay 20 07:03 ET

Compugen 1Q Rev $2.56M >CGEN.TV

Compugen 1Q Rev $2.56M >CGEN.TV

Dow JonesMay 20 07:02 ET

Express News | Compugen Ltd: Solid Balance Sheet With Extended Cash Runway Expected to Fund Operations Into 2027

ReutersMay 20 07:01 ET

Compugen: Silberman Succeeds Alberto Sessa as Chief Financial Officer >CGEN

Compugen: Silberman Succeeds Alberto Sessa as Chief Financial Officer >CGEN

Dow JonesMay 15 07:05 ET

Express News | Compugen Ltd - Appointment of David Silberman as Its New Chief Financial Officer Effective August 15, 2024

ReutersMay 15 07:00 ET